Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05FQD
|
||||
Former ID |
DNCL002685
|
||||
Drug Name |
Metaiodobenzylguanidine I-131
|
||||
Synonyms |
Azedra (TN)
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Neuroblastoma [ICD9: 194.0, 194.5, 194.6, 227.0, 227.5, 227.6, 237.3, 255.6; ICD10:C74.1, C74.9, C75.4, C75.5, D35.0, D35.5, D35.6, D44.6, D44.7] | Phase 2 | [545811] | ||
Company |
Molecular Insights Pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Formula |
C8H10IN3
|
||||
Canonical SMILES |
C1=CC(=CC(=C1)I)CN=C(N)N
|
||||
InChI |
1S/C8H10IN3/c9-7-3-1-2-6(4-7)5-12-8(10)11/h1-4H,5H2,(H4,10,11,12)/i9+4
|
||||
InChIKey |
PDWUPXJEEYOOTR-JRGAVVOBSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Sodium-dependent noradrenaline transporter | Target Info | Modulator | [532685] | |
PANTHER Pathway | Adrenaline and noradrenaline biosynthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.